IRIS
Demichelis, Francesca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 15.183
AS - Asia 4.565
EU - Europa 3.747
SA - Sud America 829
Continente sconosciuto - Info sul continente non disponibili 380
AF - Africa 111
OC - Oceania 38
Totale 24.853
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.962
SG - Singapore 1.903
CN - Cina 851
IT - Italia 779
VN - Vietnam 733
BR - Brasile 677
RU - Federazione Russa 543
FI - Finlandia 424
DE - Germania 360
GB - Regno Unito 313
SE - Svezia 313
HK - Hong Kong 277
UA - Ucraina 272
FR - Francia 218
LV - Lettonia 160
KR - Corea 145
IN - India 140
CA - Canada 136
BD - Bangladesh 91
ID - Indonesia 70
BG - Bulgaria 58
ES - Italia 58
AR - Argentina 57
IQ - Iraq 54
NL - Olanda 50
JP - Giappone 48
ZA - Sudafrica 46
TR - Turchia 44
MX - Messico 42
PL - Polonia 42
AT - Austria 41
JO - Giordania 38
AU - Australia 33
PK - Pakistan 30
LU - Lussemburgo 22
VE - Venezuela 22
CO - Colombia 19
PH - Filippine 17
MA - Marocco 16
EC - Ecuador 15
UZ - Uzbekistan 14
AE - Emirati Arabi Uniti 13
LT - Lituania 13
CL - Cile 12
CZ - Repubblica Ceca 12
IE - Irlanda 11
PY - Paraguay 11
BE - Belgio 10
NP - Nepal 10
SA - Arabia Saudita 10
KE - Kenya 9
TH - Thailandia 9
TN - Tunisia 9
CH - Svizzera 8
CR - Costa Rica 8
LB - Libano 8
RO - Romania 8
UY - Uruguay 8
EG - Egitto 7
IL - Israele 7
NO - Norvegia 6
PE - Perù 6
TW - Taiwan 6
AZ - Azerbaigian 5
DZ - Algeria 5
ET - Etiopia 5
IR - Iran 5
JM - Giamaica 5
NG - Nigeria 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
DO - Repubblica Dominicana 4
GT - Guatemala 4
KG - Kirghizistan 4
KH - Cambogia 4
KZ - Kazakistan 4
OM - Oman 4
EU - Europa 3
GR - Grecia 3
MY - Malesia 3
NI - Nicaragua 3
PA - Panama 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AO - Angola 2
BB - Barbados 2
BH - Bahrain 2
BN - Brunei Darussalam 2
BO - Bolivia 2
CI - Costa d'Avorio 2
EE - Estonia 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
HT - Haiti 2
LA - Repubblica Popolare Democratica del Laos 2
LK - Sri Lanka 2
Totale 24.452
Salva come PNG Salva come JPEG
Città #
Fairfield 1.720
Ashburn 1.510
Singapore 1.152
Chandler 956
Woodbridge 791
Seattle 707
San Jose 678
Houston 640
Jacksonville 612
Cambridge 587
Wilmington 569
Dallas 456
Columbus 418
Santa Clara 397
Los Angeles 367
San Mateo 334
Ann Arbor 330
Council Bluffs 278
Helsinki 270
Hong Kong 248
Moscow 246
Trento 232
Princeton 227
New York 202
Beijing 201
The Dalles 193
Ho Chi Minh City 188
Hanoi 176
Riga 160
Munich 156
Lauterbourg 142
Seoul 134
Boardman 120
San Diego 120
London 99
Dearborn 79
Chicago 77
Milan 75
Buffalo 70
Lawrence 70
Orem 70
São Paulo 65
Jakarta 60
San Francisco 60
Phoenix 59
Sofia 58
Como 56
Dong Ket 50
Da Nang 43
Nuremberg 42
Frankfurt am Main 41
Falls Church 40
Redondo Beach 39
Chennai 38
Montreal 37
Tokyo 35
Bremen 34
Hefei 34
Brooklyn 33
Denver 33
Salt Lake City 32
Toronto 32
Warsaw 32
Johannesburg 29
Boston 28
Rome 28
Norwalk 27
San Paolo di Civitate 27
Atlanta 24
Brasília 24
Haiphong 23
Shanghai 23
Tolentino 23
Washington 23
Guangzhou 22
Hesperange 22
Altamura 21
Belo Horizonte 21
Des Moines 21
Dublin 21
Turku 21
Baghdad 20
Bend 20
Mumbai 20
Elk Grove Village 19
Melbourne 19
Rio de Janeiro 19
Vancouver 18
Curitiba 17
Manchester 17
Vienna 17
Barcelona 16
Changsha 16
Izmir 16
Kilburn 16
Düsseldorf 15
Lappeenranta 15
St Louis 15
Amsterdam 13
Andover 13
Totale 17.759
Salva come PNG Salva come JPEG
Nome #
Hit and go CAS9 delivered through a lentiviral based self-limiting circuit 379
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer 373
SOX2 promotes lineage plasticity and antiandrogen resistance in TP53-and RB1-deficient prostate cancer 341
A highly specific SpCas9 variant is identified by in vivo screening in yeast 339
Inherited determinants of early recurrent somatic mutations in prostate cancer 337
Genomic correlates of clinical outcome in advanced prostate cancer 290
Ultrasensitive detection of cancer biomarkers by nickel-based isolation of polydisperse extracellular vesicles from blood 276
ETS-related gene (ERG) undermines genome stability in mouse prostate progenitors via Gsk3β dependent Nkx3.1 degradation 272
A hierarchical Naïve Bayes Model for handling sample heterogeneity in classification problems: an application to tissue microarrays. 256
Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study 254
Personalized in vitro and in vivo cancer models to guide precision medicine 250
ASEQ: Fast allele-specific studies from next-generation sequencing data 244
A novel brain tumour model in zebrafish reveals the role of YAP activation in MAPK- and PI3K-induced malignant growth 244
Patient derived organoids to model rare prostate cancer phenotypes 238
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer 228
Second Generation Imaging of Nuclear/Cytoplasmic HIV-1 Complexes. 226
EthSEQ: ethnicity annotation from whole exome sequencing data 226
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers 226
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer 213
The long tail of oncogenic drivers in prostate cancer 212
An evaluation of the use of and user satisfaction with a teleconsultation system in oncology practice. 209
RB1 heterogeneity in advanced metastatic castration-resistant prostate cancer 206
Ancestry-specific predisposing germline variants in cancer 205
Analysis of user-satisfaction with the use of a teleconsultation system in oncology. 203
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 200
Clonal evolution of chemotherapy-resistant urothelial carcinoma 199
PaCBAM: Fast and scalable processing of whole exome and targeted sequencing data 188
An automated procedure to properly handle digital images in large scale tissue microarray experiments. 186
The Molecular Taxonomy of Primary Prostate Cancer 182
TPES: Tumor Purity Estimation from SNVs 181
A computational framework discovers new copy number variants with functional importance. 178
ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA 175
Sterile inflammation via TRPM8 RNA-dependent TLR3-NF-kB/IRF3 activation promotes antitumor immunity in prostate cancer 173
In-silico identification and functional validation of allele-dependent AR enhancers 172
A step toward functionally characterized prostate cancer molecular subtypes. 169
Molecular sampling of prostate cancer: a dilemma for predicting disease progression. 168
The landscape of somatic copy-number alteration across human cancers. 168
Charting differentially methylated regions in cancer with Rocker-meth 168
High-throughput sequencing of two populations of extracellular vesicles provides an mRNA signature that can be detected in the circulation of breast cancer patients 167
N-myc downstream regulated gene 1 (NDRG1) is fused to ERG in prostate cancer. 166
Core Biopsies from Prostate Cancer Patients in Active Surveillance Protocols Harbor PTEN and MYC Alterations 165
Defining order and timing of mutations during cancer progression: The TO-DAG probabilistic graphical model 164
Antibody-based detection of ERG rearrangement-positive prostate cancer. 163
Analytical protocol to identify local ancestry-associated molecular features in cancer 161
The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models. 159
Fast mutual exclusivity algorithm nominates potential synthetic lethal gene pairs through brute force matrix product computations 158
Testing mutual exclusivity of ETS rearranged prostate cancer. 156
Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets 155
Tumor purity quantification by clonal DNA methylation signatures 155
A Comparative Study of ERG Status Assessment on DNA, mRNA, and Protein Levels Using Unique Samples from a Swedish Biopsy Cohort. 154
Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer 152
EML4-ALK fusion lung cancer: a rare acquired event. 151
Genomic correlates to the newly proposed grading prognostic groups for prostate cancer 150
Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer. 149
Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase. 149
Rearrangements of the RAF kinase pathway in prostate cancer, gastric cancer and melanoma. 149
Digital Pathology: Science Fiction? 149
Role of non-coding sequence variants in cancer 148
Better screened than sorry!-an informed panel of inherited DNA repair gene variants for prostate cancer screening and prognostication 148
Plasma AR and abiraterone-resistant prostate cancer 147
Allele-informed copy number evaluation of plasma DNA samples from metastatic prostate cancer patients: the PCF_SELECT consortium assay 147
Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer. 146
Variants at IRX4 as prostate cancer expression quantitative trait loci. 143
TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer. 143
Large Oncosomes in Human Prostate Cancer Tissues and in the Circulation of Mice with Metastatic Disease 143
The genomic complexity of primary human prostate cancer. 143
Assessing the significance of chromosomal aberrations in cancer: methodology and application to glioma. 143
SLC45A3-ELK4 is a novel and frequent erythroblast transformation-specific fusion transcript in prostate cancer. 142
Oncogene-mediated alterations in chromatin conformation 142
M-CAM expression as marker of poor prognosis in epithelial ovarian cancer. 142
Punctuated evolution of prostate cancer genomes. 141
Recurrent prostate cancer genomic alterations predict response to brachytherapy treatment 141
Automated immunofluorescence analysis defines microvessel area as a prognostic parameter in clear cell renal cell cancer. 140
PCAT-1, a long noncoding RNA, regulates BRCA2 and controls homologous recombination in cancer 140
Integrating extracellular vesicle and circulating cell-free DNA analysis on a single plasma aliquot improves the detection of HER2 positivity in breast cancer patients 139
TMPRSS2-ERG fusion heterogeneity in multifocal prostate cancer: clinical and biologic implications. 139
Oncosome formation in prostate cancer: association with a region of frequent chromosomal deletion in metastatic disease. 139
The virtual case: a new method to completely digitize cytological and histological slides. 139
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohort. 138
TMABoost: an integrated system for comprehensive management of tissue microarray data. 138
Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer. 138
Digital storage of glass slides for quality assurance in histopathology and cytopathology. 138
Mutation–selection balance and compensatory mechanisms in tumour evolution 138
Noninvasive Detection of Neuroendocrine Prostate Cancer through Targeted Cell-free DNA Methylation 137
JAGGED1 expression is associated with prostate cancer metastasis and recurrence. 137
Epigenetic Repression of miR-31 Disrupts Androgen Receptor Homeostasis and Contributes to Prostate Cancer Progression 137
Large oncosomes mediate intercellular transfer of functional microRNA. 136
Optimizing copy number variation analysis using genome-wide short sequence oligonucleotide arrays. 136
Skp2 expression is associated with high risk and elevated Ki67 expression in gastrointestinal stromal tumours. 136
Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer 136
User attitudes in analyzing digital slides in a quality control test bed: a preliminary study. 135
Tumor clone dynamics in lethal prostate cancer 134
Next-generation rapid autopsies enable tumor evolution tracking and generation of preclinical models 134
Circulating RNAs in prostate cancer patients 134
Distinct ERG rearrangement prevalence in prostate cancer: higher frequency in young age and in low PSA prostate cancer. 133
Robotic telepathology for intraoperative remote diagnosis using a still-imaging-based system. 133
Comparative genomics of primary prostate cancer and paired metastases: insights from 12 molecular case studies 133
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. 132
Design and initial implementation of a regional tele-oncology project. 131
Recurrent gene fusions in prostate cancer 131
Totale 17.696
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.030
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 816
selected - selezionate 0
volume - volumi 481
Totale 106.327
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.581 0 0 14 92 36 81 83 390 137 212 181 355
2022/20232.024 267 235 13 328 210 316 30 145 252 34 122 72
2023/2024822 49 77 67 28 76 177 45 92 10 80 32 89
2024/20253.676 18 36 235 669 246 461 205 220 390 578 281 337
2025/20268.301 632 263 978 1.087 869 542 1.454 235 757 620 488 376
2026/2027795 281 479 35 0 0 0 0 0 0 0 0 0
Totale 24.853